Point72 Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.05M | Buy |
+184,478
| New | +$8.05M | 0.02% | 627 |
|
|
2023
Q4 | – | Sell |
-81,400
| Closed | -$1.13M | – | 1748 |
|
|
2023
Q3 | $1.13M | Buy |
+81,400
| New | +$1.13M | ﹤0.01% | 893 |
|
|
2022
Q2 | – | Sell |
-652,800
| Closed | -$27.6M | – | 1196 |
|
|
2022
Q1 | $27.6M | Buy |
652,800
+594,600
| +1,022% | +$25.2M | 0.11% | 224 |
|
|
2021
Q4 | $3.7M | Sell |
58,200
-99,200
| -63% | -$6.3M | 0.01% | 683 |
|
|
2021
Q3 | $9.25M | Buy |
157,400
+89,800
| +133% | +$5.28M | 0.04% | 476 |
|
|
2021
Q2 | $3.28M | Buy |
+67,600
| New | +$3.28M | 0.01% | 627 |
|